Yekaterina Chudnovsky - 11 Jun 2024 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role: Director, 10%+ Owner
Signature: /s/ Yekaterina Chudnovsky
Issuer symbol: IMMX
Transactions as of: 11 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 21 Jun 2024, 17:45:16 UTC
Previous filing: 27 Sep 2024
Next filing: 02 Jul 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IMMX	Common Stock						3,241,076	11 Jun 2024	Held by GKCC, LLC	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMMX	Stock Option (Right to Buy)	Award	$0	+33,000		$0.000000	33,000	11 Jun 2024	Common Stock	33,000	$2.04	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.
F2	The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.